Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Edwards Lifesciences
(NY:
EW
)
62.37
+2.67 (+4.47%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edwards Lifesciences
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Market Whipsaws Lower On Hawkish Fed, Tesla; Apple, Microsoft Earnings Strong: Weekly Review
January 28, 2022
Microsoft and Apple earnings were strong, but the correction is getting worse.
Via
Investor's Business Daily
Where Edwards Lifesciences Stands With Analysts
January 27, 2022
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:
Via
Benzinga
Edwards Lifesciences Q4 Earnings Fall Short Of Expectations, Reaffirms FY22 Outlook
January 27, 2022
Heart device company Edwards Lifesciences Corp (NYSE: EW) posted Q4 adjusted EPS of $0.51, compared to $0.50 posted a year ago and below the consensus of $0.55....
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 26, 2022
Gainers Reneo Pharmaceuticals (NASDAQ:RPHM
Via
Benzinga
Edwards Lifesciences Dips On Narrow Quarterly Miss, Light Outlook
January 26, 2022
Edwards issued light 2022 guidance after a fourth-quarter disappointment.
Via
Investor's Business Daily
Watch for Continued Gains in Shares of Edwards Lifesciences Corporation (EW)
December 17, 2021
Via
Investor Brand Network
Expert Ratings For Edwards Lifesciences
October 28, 2021
Edwards Lifesciences (NYSE:EW) has observed the following analyst ratings withi...
Via
Benzinga
Edwards Lifesciences: Q4 Earnings Insights
January 26, 2022
Edwards Lifesciences (NYSE:EW) reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
January 26, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
5 Big Cap Earnings All Stars to Watch This Week
January 25, 2022
Some of these companies have perfect 5-year earnings surprise track records, even beating through the early months of the pandemic. It’s impressive.
Via
Talk Markets
Preview: Edwards Lifesciences's Earnings
January 25, 2022
Edwards Lifesciences (NYSE:EW) is set to give its latest quarterly earnings report on Wednesday, 2022-01-26. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
January 23, 2022
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the...
Via
Benzinga
Earnings Scheduled For January 26, 2022
January 26, 2022
Companies Reporting Before The Bell • Blue Foundry (NASDAQ:BLFY) is projected to report earnings for its fourth quarter. • First BanCorp (NYSE:FBP) is likely to...
Via
Benzinga
$100 Invested In This Stock 10 Years Ago, Would Be Worth This Much
January 10, 2022
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 10 years by 12.27% on an annualized basis. Buying $100 In EW: 10 years ago, an investor could have...
Via
Benzinga
Where Edwards Lifesciences Stands With Analysts
January 07, 2022
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW)...
Via
Benzinga
CNBC's Final Trades: Match Group, PayPal, Edwards Lifesciences And This Hospitality Major
December 23, 2021
On CNBC’s “Halftime Report Final ...
Via
Benzinga
Edwards Lifesciences Corp. (EW) Looks to Continue to Trade Above its Annual-High Share Price Today
December 22, 2021
Via
Investor Brand Network
Jim Cramer Shares His Thoughts On Medtronic, Peloton Interactive And More
December 20, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Duluth Holdings Inc. (NASDAQ:
Via
Benzinga
Watch for Continued Gains in Shares of Edwards Lifesciences Corporation
December 17, 2021
Edwards Lifesciences Corporation (NYSE: EW) traded at a new 12-month high today of $123.56. So far today approximately 1.6 million shares have been exchanged, as compared to an...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
December 15, 2021
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021
December 17, 2021
Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ:
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
December 15, 2021
Barclays boosted the price target on Sysco Corporation (NYSE:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:
Via
Benzinga
10 Biggest Price Target Changes For Friday
December 10, 2021
Keybanc boosted the price target on Broadcom Inc. (NASDAQ:
Via
Benzinga
Where Edwards Lifesciences Stands With Analysts
December 09, 2021
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW)...
Via
Benzinga
10 Biggest Price Target Changes For Thursday
December 09, 2021
SVB Leerink boosted the price target on Edwards Lifesciences Corporation (NYSE:
Via
Benzinga
Notable Edwards Lifesciences Insider Trades $4.9M In Company Stock
November 10, 2021
Michael Mussallem, Chairman And CEO at Edwards Lifesciences (NYSE:EW), made a large buy and sell of company shares on November 9, according to a new SEC filing. What Happened: A...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Edwards' Transcatheter Tricuspid Replacement System Shows Favorable Patient Outcomes
November 08, 2021
Edwards Lifesciences Corporation (NYSE: EW) announced results from the TRISCEND study of its EVOQUE transcatheter tricuspid valve replacement system. Patients...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
Upgrades According to TD Securities, the prior rating for MAG Silver Corp (AMEX:
Via
Benzinga
Edwards Lifesciences Says Delta Variant Drove Procedure Deferrals In Q3
October 28, 2021
Edwards Lifesciences Corp (NYSE: EW) reported Q3 earnings of $340.1 million, or $0.54 per share, ahead of the consensus of $0.53. Sales grew 15% to $1.31 billion;...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.